Scientific Program
All times indicated are Hong Kong Time (UTC +8).
Venue: Meeting Rooms S421-430, Level 4, Hong Kong Convention and Exhibition Centre
Room S421 – Virtual Room 1 |
||||||
Time |
Session & Topic & Speaker |
|||||
0800-0915 |
Korean Society of Cardiology @HKCC ASC: Advances in Pacing and Cardiac Electrophysiology |
|||||
0800-0825 |
AI and computational modeling for patient and target selections of AF ablation |
Prof. Hui Nam Pak |
||||
0825-0850 |
Orthodromic and antidromic snare techniques for left ventricular lead implantation in challenging coronary venous anatomy |
Prof. Seung Jung Park |
||||
0850-0915 |
When CRT is not an option - What’s next? |
Dr. Jo Jo Siu-han Hai |
||||
0915-1015 |
Oral Abstracts Presentation |
0900-0950 |
Best Poster Presentation Chairpersons & Judges: Dr. Brian CH Chau, Dr. Sze-wah Lai, Dr. Chun-leung Lau, Dr. Eric Chi-yuen Wong |
|||
| 0915-0925 | Blood pressure is related to alcohol consumption in the Chinese general population | Dr. Juanying Zhen | 0900-0907 | Visceral adiposity index and sex differences in relation to peripheral artery disease in normal-weight adults with hypertension | Dr. Yumeng Shi | |
| 0925-0935 | Comparison of the potency of Atorvastatin, Rosuvastatin and Simvastatin among Chinese patients initiated with lipid-lowering therapy | Ms. Hui Sun | 0907-0914 | Clinical outcome of patients referred for advanced heart failure therapy related to utilization of short term mechanical circulatory support for cardiogenic shock in Hong Kong | Dr. Michael Ka-lam Wong | |
| 0935-0945 | Next generation sequencing analysis of hereditary cardiomyopathy and channelopathy in Hong Kong – Latest update from a regional centre | Dr. Jeremiah Sik-bit Tseung | 0914-0921 | Genetic variants of ISL1 gene promoter in atrial septal defects and analysis of cellular function | Ms. Xiu-yun Yin | |
| 0945-0955 | Digital nail-fold capillaroscopy to evaluate the efficacy and safety of oral anticoagulation therapy | Prof. Simon Matskeplishvili | 0921-0928 | High power short duration (HPSD) ablation results in low esophageal thermal injury rates and improved procedural outcomes versus conventional lower power longer duration (LPLD) ablation in atrial fibrillation: The hi-lo HEAT multi-centre randomised controlled study | Dr. David Chieng | |
| 0955-1005 | Machine learning-derived echocardiographic phenotypes predict outcome in tricuspid annuloplasty | Ms. Denise Hung | 0928-0935 | Microvascular dysfunction reflected by a novel angiography-derived index is associated with heart failure hospitalization in patients with non-obstructive coronary artery disease | Mr. Calvin Ka-lam Leung | |
1045-1215 |
Best Abstracts Presentation |
|||||
| 1045-1100 | Clinical outcomes of left atrial appendage occlusion versus switch of direct oral anti-coagulant in atrial fibrillation | Dr. Andrew Kei-yan Ng | ||||
| 1100-1115 | Serum amyloid protein a predicts intravenous immunoglobulin resistance in Kawasaki Disease patients younger than one-year old | Dr. Xiao-bi Huang | ||||
| 1115-1130 | Impact of sodium-glucose co-transporter 2 inhibitors on cardiovascular outcomes in patients with chronic kidney disease: Hong Kong-wide, observational, propensity score matched analysis | Dr. Wen Sun | ||||
| 1130-1145 | Burden of familial hypercholesterolemia in Chinese patients with myocardial infarction: Unmet clinical needs for guideline-directed control and implications | Dr. Will Yap-hang Chan | ||||
| 1145-1200 | Development of novel human bioengineered tissue models of heart failure with preserved ejection fraction leads to first-in-man gene therapy clinical trial | Dr. Andy On-Tik Wong | ||||
1215-1300 |
EP Lunch Symposium |
|||||
|
Atrial tachycardia post AF ablation |
Prof. Rajiv Mahajan |
||||
1300-1500 |
Guidelines and Practice: Clinical Case Based Conference (GAP-CCBC) – Session 1 |
|||||
| 1300-1320 | A case of Ping-pong technique in treatment of complex high-risk and indicated patient 乒乓技術在CHIP中應用一例 |
Prof. Chuang Li 李闖教授首都醫科大學附屬北京朝陽醫院心臟中心 |
||||
| 1320-1340 | A Mviv case using SAPIEN3 trans left atrial approach 經左房途徑應用S3二尖瓣瓣衰敗置換一例 |
Prof. Yan Wang 王焱主任廈門大學附屬心血管病醫院 |
||||
| 1340-1400 | Massive pulmonary embolism treated with interventional thrombolysis | Dr. Wei-chieh Huang 黃偉杰醫生臺北榮民總醫院 |
||||
| 1400-1420 | Running out of options! Hybrid percutaneous pulmonary valve implantation with surgical right ventricular outflow tract plication | Dr. Robin Hay-son Chen 陳羲舜醫生香港兒童醫院 |
||||
| 1420-1440 | Pulmonary hypertension due to pulmonary artery obstruction - Something more than CTEPH | Dr. Angela Ho 何華醫生 仁伯爵綜合醫院 |
||||
| 1440-1500 | Rare diseases are not actually that are rare, look at them collectively! 讓罕見，被看見！ |
Prof. Chong-you Lee 李忠佑教授北京大學人民醫院 |
||||
1500-1700 |
Guidelines and Practice: Clinical Case Based Conference (GAP-CCBC) – Session 2 |
|||||
| 1500-1520 | Flow diagram of the different diagnosis and clinical decision making in a rare case of contrast-induced encephalopathy following cardiac catheterization 對比劑腦病鑒別診斷與臨床決策流程 |
Dr. Shi-wei Yang 楊士偉醫生首都醫科大學附屬北京安貞醫院 |
||||
| 1520-1540 | Cardiac tamponade after PCI procedure | Dr. Chuan-tsai Tsai 蔡泉財醫生臺北榮民總醫院 |
||||
| 1540-1600 | Consideration of focal ablation triggering from non-pulmonary vein 非肺靜脈觸發灶消融思考 |
Dr. Wei-hua Guo 郭煒華主任北京中醫藥大學附屬東直門醫院 |
||||
| 1600-1620 | A case of diffuse lesion revascularization guided by QFR QFR指引的彌漫性病變血運重建一例 |
Dr. Ruo-fei Jia 賈若飛醫生首都醫科大學附屬北京天壇醫院 |
||||
| 1620-1640 | A close month catches no files - A case of chest pain with haemstemesis 病從口入 – 胸痛伴嘔血一例 |
Dr. Zheng Wang 王征醫生北京大學第三醫院老年內科 |
||||
1700-1815 |
Asian Pacific Society of Cardiology @HKCC ASC: Advances in Coronary Intervention |
|||||
1700-1725 |
Early experience with shockwave: Early experience and patient selection |
Prof. Khung Keong Yeo |
||||
1725-1750 |
Treatment of acute coronary syndrome: What is to come? |
Prof. Junya Ako |
||||
1750-1815 |
Shockwave intravascular lithotripsy: The good, the bad and the ugly |
Dr. On-hing Kwok |
||||
|
Room S421 – Virtual Room 1 |
Room S423-424 – Virtual Room 2 |
|||
Time |
Session & Topic & Speaker |
||||
0800-1005 |
Heart Rhythm Symposium |
0820-1000 |
Diabetes and Cardiovascular Risk Factors Symposium |
||
0800-0825 |
Heart rhythm monitoring and screening in clinical practice |
Assoc. Prof. Dr. Harry Mond |
0820-0845 |
The problem with sweet heart: Role of GLP-1 RA in preventing cardiovascular events in type 2 diabetes |
Prof. Alex Pui-wai Lee |
0825-0850 |
Recent advancements in screening for atrial fibrillation – Risk prediction, diagnosis and clinical outcomes |
Prof. Ben Freedman |
0845-0910 |
Oral semaglutide: An evidence based approach to adoption of therapy |
Prof. Michael Farkouh |
0850-0915 |
Novel ventricular arrhythmias detection to manage challenging life-threatening undersensing |
Dr. Michael Katcher |
0910-0935 |
Influence of cholesterol level on long-term survival and cardiac events after surgical coronary revascularization |
Dr. Kevin Lim |
0915-0940 |
Never ending debate: Rate or rhythm control for AF |
Dr. Wing-hong Fung |
0935-1000 |
Diabetes: More than just a thromboembolic risk factor in NVAF patients (Sponsored by Bayer HealthCare) |
Prof. Christian Ruff |
| 0940-1005 | Watchman FLX: A choice to hold back oral anticoagulation in atrial fibrillation (Sponsored by Boston Scientific) |
Dr. Raymond Chi-yan Fung | |||
1005-1100 |
Break / Exhibition / E-poster Viewing |
||||
1100-1230 |
Heart Failure Symposium I |
||||
1100-1130 |
Recent advances in the treatment of worsening heart failure |
Dr. Lisa Mielniczuk |
|||
1130-1200 |
How to incorporate SGLT2 inhibitors into existing treatment strategies for heart failure? |
Prof. Javed Butler |
|||
1200-1230 |
Cardiovascular and Renal benefits of ARNI in heart failure |
Dr. |
|||
1230-1350 |
Lunch Symposium |
||||
|
Putting the new standard of care of HFrEF treatment into practice |
Prof. Dr. Michael Böhm |
|||
1400-1415 |
Opening Ceremony |
||||
1415-1445 |
Hong Kong Heart Foundation Lecture |
|
|
|
|
|
Risk prediction for adverse cardiovascular events: Experience from precision cardiovascular imaging to the application of big data analytics |
Prof. Kai-hang Yiu |
|||
1445-1545 |
HKCC 30th Anniversary Keynote Lecture cum Presidential Forum |
1515-1635 |
Hong Kong Heart Foundation, Dr CO Pun and Dr Mary BL Kwong Scholarship Symposium |
||
|
Development of cardiovascular medicine and Hong Kong College of Cardiology in 30 years |
Dr. Patrick Tak-him Ko |
1515-1535 |
Cardio-genetics for heart failure, ready for prime time in HK? |
Dr. Chi-yui Yung |
Moderator:
|
HKCC Presidents | ||||
1545-1630 |
Break / Exhibition / E-poster Viewing |
1535-1555 |
The journey beyond |
Dr. Guang-ming Tan |
|
1630-1745 |
European Society of Cardiology @HKCC ASC: Controversies in the Management of Coronary Artery Disease |
1555-1615 |
An intractable enemy in PCI |
Dr. Sze-wah Lai |
|
1630-1655 |
The diagnostic workup of chronic coronary artery disease and the implications of the ISCHEMIA trial |
Prof. Stephan Achenbach |
1615-1635 |
20 years down the road: What's new in TAVI |
Dr. Ivan Man-ho Wong |
1655-1720 |
ISCHEMIA trial: Impact on revascularization practice |
Dr. Marco Roffi |
|
|
|
1720-1745 |
Cruising between bleeding and thrombotic complications after percutaneous coronary intervention in Chinese patients |
Dr. Andrew Kei-yan Ng |
1730-1930 |
Coronary Ischaemia Symposium I |
|
1745-1900 |
Heart Failure Symposium II |
1730-1750 |
Evidence-based management of angina |
Prof. Peter Collins |
|
1745-1810 |
Digital solutions to identify worsening heart failure |
Prof. Mario Martins Oliveira |
1750-1810 |
PCSK9 inhibition in myocardial infarction patients: Beyond LDL-C lowering |
Prof. Stephen Nicholls |
1810-1835 |
Is there still any role of early heart rate control under the new and personalized HF management era? |
Prof. Peter Liu |
1810-1830 |
Frontiers in ACS management - Moving towards individualized antithrombotic therapy |
Prof. Robert Storey |
1835-1900 |
Iron deficiency in heart failure: Clinical significance and treatment |
Dr. Godwin Tat-chi Leung |
1830-1850 |
Impella patient selection and therapy escalation to ECPELLA – When & how |
Dr. Christian Napp |
|
|
|
1850-1910 |
What is the next beyond DES? A novel “uncaging” platform for coronary revascularization |
Dr. Jaclyn Chi-lin Chan |
1910-1930 |
How OCT imaging changed my treatment decisions |
Dr. Shozo Ishihara |
|||
|
Room S421 – Virtual Room 1 |
Room S426-427 – Virtual Room 3 |
|||
Time |
Session & Topic & Speaker |
||||
0800-0915 |
Coronary Ischaemia Symposium II |
|
|
||
0800-0825 |
Sustained Limus Release (SLR) drug-eluting balloon: The new paradigm for complex PCI |
Dr. Houng Bang Liew |
|||
0825-0850 |
Insights from guidelines to real world practice: Individualized approach for angina management |
Dr. David Kwang-leng Quek |
|||
0850-0915 |
Vascular effects of PCSK9i in acute myocardial infarction |
Prof. Chung-wah Siu |
|||
0915-1055 |
American College of Cardiology @HKCC ASC: Hot Issues in Cardiology |
||||
0915-0940 |
Facing the inevitable: Addressing the international crisis and physician burnout |
Dr. Hadley Wilson |
|||
0940-1005 |
Antiplatelet therapy in high bleeding risk patients: Latest evidence |
Dr. Roxana Mehran |
|||
1005-1030 |
Robotic PCI: Combining skill & technology for the future |
Dr. Michael Kang-yin Lee |
|||
1030-1055 |
Endovascular interventions for severe manifestations of venous thromboembolism: Our Hong Kong experience |
Prof. Bryan Ping-yen Yan |
|||
1055-1115 |
Break / Exhibition / E-poster Viewing |
||||
1115-1230 |
Atrial Fibrillation Symposium |
||||
1115-1140 |
Comparative effectiveness of oral anticoagulants in everyday practice: Worldwide and Local data |
Prof. Alex Pui-wai Lee |
|||
1140-1205 |
Managing elderly patients with atrial fibrillation-evidence from RCT’s and observational data |
Dr. Kevin Ka-ho Kam |
|||
1205-1230 |
Persistent AF Treatment – PVI and Beyond (Sponsored by Johnson & Johnson) |
Dr. Yuet-wong Cheng |
|||
1230-1430 |
Lunch Symposium |
||||
|
How does innovation transform the way we treat LDL-C in patients with ASCVD? |
Prof. Kausik Ray |
|||
1430-1630 |
Best Challenging/Interesting Cardiac Intervention Cases Presentation |
1400-1500 |
Symposium on Under-recognized Aspects in Cardiovascular Diseases |
||
| 1430-1450 | One bird two stones: Mitraclip for Commissural Mitral Regurgitation (MR) and Systolic Anterior Motion (SAM) in Hypertrophic obstructive cardiomyopathy (HOCM) | Dr. Leo Kar-lok Lai | 1400-1430 |
Holistic pulmonary arterial hypertension management - Best practice from a pulmonary hypertension centre |
Dr. Daniel Knight |
| 1450-1510 | Plug and clip: Percutaneous repair of a perforated mitral valve complicating severe functional mitral regurgitation | Dr. Leo Kar-lok Lai | 1430-1500 |
How shall we manage hyperuricaemia in patients with cardiovascular comorbidities? |
Dr. Pui-shan Chan |
| 1510-1530 | Mechanical thrombectomy for devastating embolic stroke after emergent cardioversion for severe aortic stenosis with cardiogenic shock | Dr. Chun-kit Wong | 1500-1600 |
Break / Exhibition / E-poster Viewing |
|
| 1530-1550 | Use of coronary physiologic index in the treatment of a rare coexisting coronary artery fistula and severe coronary artery disease: A case report | Dr. Aiza-meriam Tahil | 1600-1805 |
British Cardio-Oncology Society @HKCC ASC: Cardio-oncology in the Era of COVID-19 Pandemic |
|
| 1550-1610 | Percutaneous left ventricular assist device circulatory support for salvage ventricular tachycardia ablation in patient with cardiogenic shock and electrical storm | Dr. Abe Ho-ting Ngan | 1600-1625 |
Role of cardiac imaging for early recognition and treatment of cardiomyopathy related to cancer treatments |
Dr. Alexander Lyon |
| 1610-1630 | Recurrent cyanotic spells in an octogenarian: Too old to have PFO? | Dr. Chun-kit Wong | 1625-1650 |
Importance of drug interactions for cardio-oncology patients |
Dr. Ka-on Lam |
1630-1650 |
Break / Exhibition / E-poster Viewing |
1650-1715 |
Oncology patients with coronary artery diseases and percutaneous coronary intervention-a special population |
Dr. Yu-ho Chan |
|
1650-1850 |
Best HKCC-HKPHCA Challenging/Interesting Clinical Cardiology Cases Presentation |
1715-1740 |
Best practice for Cardio-oncology patients in the era of COVID-19: Vaccine, treatment, tele-health and more |
Prof. Stuart Rosen |
|
1650-1710
|
Percutaneous coronary intervention combined with targeted therapy for a patient with left main coronary compression syndrome associated with atrial septal defect related pulmonary arterial hypertension |
Dr. Yuan He | 1740-1805 |
Contemporary management for AL amyloidosis |
Dr. Charlotte Manisty |
| 1710-1730 | A family of cardiomyopathy | Dr. Shing-lung Wong | |||
| 1730-1750 | A case of heart failure during the pandemic | Dr. Ricky Wang-hei Leung | |||
| 1750-1810 | Gut feeling in the heart | Dr. Chin-wai Lai | |||
| 1810-1830 | Syphilitic aortitis and ostial coronary stenosis treated by endarterectomy, bypass grafting and aortic valve replacement | Dr. Shavonne Ki-fung Ip | |||
| 1830-1850 | Right atrial mass with inflow obstruction in a patient with IgG4-related disease | Dr. Joyce Shek | |||
1850-1855 |
Closing Remarks |
||||
Program is subject to change without prior notice.
Date: 9 July 2022 (Saturday)
Room S426-427 – Virtual Room 3 |
||
Time |
Session & Topic & Speaker |
|
0825-0830 |
Welcome Address |
Dr. Tak-cheung Yung |
0830-1030 |
Paediatric Cardiology Symposium I |
|
0830-0850 |
Anatomy and physiology of the lymphatic system |
Dr. David Matthew Biko |
0850-0900 |
Q&A |
|
0900-0920 |
Modern imaging technique for the lymphatic system - MR lymphangiography |
Dr. David Matthew Biko |
0920-0930 |
Q&A |
|
0930-0950 |
My lymphatic intervention algorithm: How I improve outcome |
Dr. Yoav Dori |
0950-1000 |
Q&A |
|
1000-1030 |
Case discussion - Management of central lymphatic flow disorder in TGA patients post-arterial switch |
Dr. David Matthew Biko, Dr. Yoav Dori, Prof. Fang Liu, Dr. Kevin KF Fung |
1030-1100 |
Break / Exhibition / E-poster Viewing |
|
1100-1300 |
Free Paper Session (Abstract & Interesting Case Presentations) |
|
|
Abstract Presentation |
|
| 1100-1109 | Risk of atrial fibrillation in patients with congenital heart disease: The known, the unknowns, the unforgettable | Prof. Wei-syun Hu |
| 1109-1118 | Metabolomic profiling reveals metabolic alterations of the serum in Kawasaki Disease | Ms. Xue Fan |
| 1118-1127 | Aortic regurgitation requiring unplanned surgery following transcatheter closure of ventricular septal defect in children: Incidence and risk factors | Mr. Kaijun Zhang |
| 1127-1136 | Use of Treprostinil in pediatric patients with idiopathic pulmonary arterial hypertension —— From single center experience | Dr. Yuan He |
| 1136-1145 | Reversed potts shunt for treatment of drug-refractory idiopathic pulmonary arterial hypertension in children: A short series of three cases and review of literature | Dr. Julia Zhuo Shi |
| 1145-1154 | Accuracy of CUHK-Kawasaki Disease (CUHK-KD) score in forecasting IVIG resistance for Paediatric Kawasaki disease in Hong Kong | Dr. Enoch Chi-tak So |
| 1154-1203 | Risk factors for resistance to intravenous immunoglobulin treatment and coronary artery abnormalities in a Chinese pediatric population with Kawasaki Disease: A retrospective cohort study | Prof. Yusheng Pang |
| 1203-1212 | Expression and clinical significance of circular RNA hsa_circ_0003416 in pediatric pulmonary arterial hypertension associated with congenital heart disease | Ms. Yanyun Huang |
| 1212-1221 | Two-dimensional speckle-tracking echocardiographic study on dyssynchronous ventricular contraction for children and adolescents with wolff-parkinson-white syndrome | Dr. Kwok-lap Chan |
|
Case Presentation |
|
| 1221-1229 | Fetal and neonatal chiari network mimicking atrial myxoma | Dr. Enoch Chi-tak So |
| 1229-1237 | Right ventricular outflow tract stenting with hybrid surgical cut-down for access in a neonate with pulmonary atresia with sub-arterial type of ventricular septal defect: the decision-making, the procedure and its complication | Dr. Kwong-man Yu |
| 1237-1245 | Flail tricuspid valve: A rare cause of neonatal cyanotic heart disease – A case report | Dr. Yi-man Tsoi |
| 1245-1253 | Coronary functional study and intravascular ultrasound in a paediatric patient with known kawasaki disease complicated by thrombosed giant aneurysm and post coronary artery bypass graft | Dr. Kwok-lap Chan |
| 1253-1301 | An unusual cause of bidirectional ventricular tachycardia - Andersen-tawil syndrome | Dr. Tsun-hung Wong |
1300-1400 |
Lunch Break |
|
1415-1615 |
Paediatric Cardiology Symposium II |
|
1415-1435 |
Lymphatic intervention to lymph medicine: Part 1 - How I started a lymphatic service |
Prof. Saebeom Hur |
1435-1445 |
Q&A |
|
1445-1505 |
Lymphatic intervention to lymph medicine: Part 2 - Why understanding pathophysiology of lymphatic disease is crucial? |
Prof. Saebeom Hur |
1505-1515 |
Q&A |
|
1515-1535 |
Practical tips for success in lymphatic intervention: Lymphangiography, thoracic duct cannulation, DCMRL |
Prof. Saebeom Hur |
1535-1545 |
Q&A |
|
1545-1615 |
Q&A and Panel Discussion / Case Discussion |
Dr. Robin Hay-son Chen, Prof. Saebeom Hur, Dr. Carol Wing-kei Ng |
1615-1620 |
Closing Remarks |
Dr. Kin-shing Lun |
1630-1800 |
Adult Congenital Heart Disease (ACHD) Symposium |
|
1630-1650 |
Aortic stenting in ACHD patients: Special considerations and how to mitigate risk |
Dr. Kothandam Sivakumar |
1650-1710 |
Percutaneous pulmonary valve Implantation: Development & way forward |
Dr. Robin Hay-son Chen |
1710-1730 |
Transcatheter tricuspid valve repair: Feasibility & challenges in ACHD |
Dr. Simon Cheung-chi Lam |
1730-1750 |
Transcatheter closure of sinus venosus ASD: What? Who? How? |
Sir Prof. Shakeel Qureshi |
1750-1800 |
Q&A |
Dr. Robin Hay-son Chen, |
Program is subject to change without prior notice.
Date: 9 July 2022 (Saturday)
Room S423-424 – Virtual Room 2 |
||
Time |
Session & Topic & Speaker |
|
1000-1100 |
Session I |
|
1000-1030 |
Clinical considerations of using oral antiviral drugs for the treatment of COVID-19 |
Hon. Assoc. Prof. William Chun-ming Chui |
1030-1100 |
COVID-19: Cardiac manifestations in adults |
Dr. David Ka-yip Lo |
1100-1130 |
Break / Exhibition / E-poster Viewing |
|
1130-1230 |
Session II |
|
1130-1200 |
Nursing diary for care of myocarditis patients: From acute to home |
Ms. Mei-yi Chau |
1200-1230 |
Post myocarditis heart failure treatment: From lifestyle modification to device therapy |
Dr. Chi-yui Yung |
Program is subject to change without prior notice.
Date: 10 July 2022 (Sunday)
Room S423-424 – Virtual Room 2 |
||
Time |
Session & Topic & Speaker |
|
0900-1030 |
Session 1 - Preventive Cardiology: Expanding the Role of GP in Cardiology |
|
0900-0930 |
Managing patients on aspirin for 1° and 2° prevention |
Dr. Danny Hoi-fan Chow |
0930-1000 |
Cardiovascular disease prevention by diet modification |
Dr. Jason Kwok-chun Ko |
1000-1030 |
Use of high-intensity statins in primary care setting and in secondary prevention (Sponsored by Viatris Healthcare) |
Dr. Andrew Kei-yan Ng |
1030-1100 |
Break / Exhibition / E-poster Viewing |
|
1100-1230 |
Session 2 - Cardiology Updates: New Guidelines in Clinical Practice |
|
1100-1130 |
What primary care providers should know about cardiac pacing in 2022? |
Dr. Jacky Kit Chan |
1130-1200 |
Evolution of HF management: Making sense of latest ESC & ACC guidelines |
Dr. Elaine Mo-chee Chau |
1200-1230 |
Approach to chest pain evaluation |
Dr. Yuk-kong Lau |
1230-1400 |
Lunch Break |
|
1400-1530 |
Session 3 - Common Cardiology Challenges in General Practice |
|
1400-1430 |
"De-escalation" of antiplatelet therapy in high bleeding risk patients |
Dr. Alan Ka-chun Chan |
1430-1500 |
Incorporating SGLT2i in clinical practice for CV and renal risk reductionk |
Dr. Thomas Tunggal |
1500-1530 |
Novel strategies to achieve lipid goals |
Dr. Frankie Chor-cheung Tam |
1530-1600 |
Break / Exhibition / E-poster Viewing |
|
1600-1700 |
Session 4 - Cardiology Issues in Women & Paediatrics |
|
1600-1615 |
Heart failure in women: Causes, consequence and management |
Dr. Michael Ka-lam Wong |
1615-1630 |
Hypertension in women: Risk factors, monitoring and treatment |
Dr. Raymond Chi-yan Fung |
1630-1645 |
Clinical approach to palpitations and syncope in paediatric patients |
Dr. Sit-yee Kwok |
1645-1700 |
Clinical approach to chest pain in paediatric patients |
Dr. Kwok-chiu Chan |
Program is subject to change without prior notice.
Date: 10 July 2022 (Sunday)
Room S426-427 |
||
Time |
Session & Topic |
Speaker |
0900-1000 |
Workshop 1: Vascular OCT Hands-on Workshop - MODERN PCI: How AI Assists Your Daily Procedure? * |
Dr. Simon Lam |
1000-1100 |
Break / Exhibition / E-poster Viewing |
|
1100-1200
|
Workshop 2: How to Overcome Challenges in Micra Implantation? |
|
Case 1 - Catheter manipulation tips and tricks |
Dr. Ling-ling Ip |
|
| Case 2 - Micra snaring technique Panel Discussion |
Dr. Yuet-wong Cheng | |
| Case 3 - Echo guided micra implantation Panel Discussion |
Dr. Michael Ka-lam Wong | |
Room S428 |
||
Time |
Session & Topic |
Speaker |
1000-1230 |
Workshop 3: Impella Workshop * Session 1 |
|
| Part I: Access management tips and tricks | Dr. Esmond Fong | |
| Part II: Patient management troubleshooting | Dr. Sunny Tsang | |
|
||
* For physical participants only, limited seats are available on first-come-first served basis.
Program is subject to change without prior notice.